We are live on ! Find out more
Clearstead Advisors

Clearstead Advisors Portfolio holdings

AUM $10.8B Turnover 17.51%
1-Year Est. Return 17.88%
 

Clearstead Advisors is an independent investment adviser that began in 1989 as Hartland & Co and was renamed Clearstead in 2018. Its main approach is to spread client portfolios across asset classes, regions, company sizes and styles, while some of its rules-based strategies can move money into money market, gold or investment-grade bond funds as a defense. Through its ClearAccess platform, clients can invest in alternative managers one by one, or through a hedge fund series or a private equity series. In 2026 Clearstead took over the clients of The Clarius Group. Flexpoint Ford holds the majority ownership, with the firm's employees holding the rest.

This Fund
S&P 500
This Quarter Est. Return
+1.18%
1 Year Est. Return
+17.88%
3 Year Est. Return
+79.54%
5 Year Est. Return
+82.82%
10 Year Est. Return
+264.8%
AUM
$10.8B
AUM Growth
+$198M
Cap. Flow
+$184M
Cap. Flow %
1.7%
Top 10 Hldgs %
29.69%
Holding
3,935
New
268
Increased
1,353
Reduced
1,363
Closed
421
Avg Time Held Equity + Options
2.3 years
Top 10 Avg Time Held Equity + Options
3.2 years
Top 20 Avg Time Held Equity + Options
3.2 years
Avg Time Held Equity only
2.3 years
Top 10 Avg Time Held Equity only
3.2 years
Top 20 Avg Time Held Equity only
3.3 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 61.02%
2 Technology 12.85%
3 Industrials 7.3%
4 Financials 5.21%
5 Consumer Discretionary 3.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
STOK icon
3826
Stoke Therapeutics
STOK
$1.74B
– –
-3
Closed -$99 –
STXS icon
3827
Stereotaxis
STXS
$109M
– –
-9
Closed -$16 –
SUPN icon
3828
DELISTED
Supernus Pharmaceuticals
SUPN
– –
-8
Closed -$373 –
SVOL icon
3829
Simplify Volatility Premium ETF
SVOL
$461M
– –
-1,206
Closed -$19.3K –
SVRA icon
3830
Savara
SVRA
$992M
– –
-3
Closed -$19 –
SXI icon
3831
Standex International
SXI
$2.76B
– –
-1
Closed -$358 –
TALK icon
3832
DELISTED
Talkspace
TALK
– –
-7
Closed -$37 –
TARA icon
3833
Protara Therapeutics
TARA
$136M
– –
-3
Closed -$12 –
TARS icon
3834
Tarsus Pharmaceuticals
TARS
$3.38B
– –
-6
Closed -$378 –
TASK icon
3835
TaskUs
TASK
$834M
– –
-8
Closed -$39 –
TBPH icon
3836
DELISTED
Theravance Biopharma
TBPH
– –
-8
Closed -$136 –
TCX icon
3837
Tucows
TCX
$142M
– –
-2
Closed -$27 –
TG icon
3838
Tredegar Corp
TG
$188M
– –
-18
Closed -$144 –
TITN icon
3839
Titan Machinery
TITN
$521M
– –
-3
Closed -$64 –
TMC icon
3840
TMC The Metals Company
TMC
$1B
– –
-47
Closed -$209 –
TMHC icon
3841
DELISTED
Taylor Morrison
TMHC
– –
-60
Closed -$4.3K –
TMQ icon
3842
Trilogy Metals
TMQ
$390M
– –
-2
Closed -$8 –
TNC icon
3843
Tennant Co
TNC
$1.22B
– –
-7
Closed -$613 –
TNXP icon
3844
Tonix Pharmaceuticals
TNXP
$81.3M
– –
-57
Closed -$728 –
TRAK icon
3845
ReposiTrak
TRAK
$123M
– –
-1
Closed -$9 –
TRC icon
3846
Tejon Ranch
TRC
$461M
– –
-7
Closed -$131 –
TROX icon
3847
Tronox
TROX
$401M
– –
-30
Closed -$190 –
TRS icon
3848
TriMas Corp
TRS
$1.39B
– –
-9
Closed -$407 –
TRTX icon
3849
TPG RE Finance Trust
TRTX
$512M
– –
-37
Closed -$311 –
TSLX icon
3850
Sixth Street Specialty
TSLX
$1.69B
– –
-18,463
Closed -$317K –

Similar funds

Clearstead Advisors's Q3 2026 Portfolio in Review

As of Q3 2026, Clearstead Advisors held 3,935 positions worth $10.8B, up 1.9% from $10.6B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Clearstead Advisors's Q3 2026 filing shows 268 new, 1,353 increased, 1,363 reduced and 421 closed positions. Its largest new stake was Criteo S.A.: 105,734 shares worth $1.61M. The largest sale was Capital Group Global Equity ETF, an estimated $34.4M.

By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, down from 61% a quarter earlier, followed by Technology and Industrials.

  • Clearstead Advisors's largest Q3 2026 buy was Criteo S.A.: 105,734 shares worth $1.61M.
  • Clearstead Advisors added most to PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q3 2026, an estimated $95.3M increase.
  • Clearstead Advisors's biggest Q3 2026 reduction was Capital Group Global Equity ETF, cutting an estimated $34.4M.
  • Clearstead Advisors fully exited iShares 0-5 Year High Yield Corporate Bond ETF in Q3 2026, selling an estimated $11.5M.
  • Clearstead Advisors's ten largest holdings make up 30% of its $10.8B portfolio in Q3 2026.
  • Clearstead Advisors opened 268 new positions and closed 421 in Q3 2026.
  • Clearstead Advisors's portfolio value rose 1.9% quarter-over-quarter to $10.8B.

Based on Clearstead Advisors's 13F filing for Q3 2026, filed 6 Nov 2026.